Altogether, our global proteomics analysis identified that TMSB4X is a newly discovered biomarker in HNSCC whose functions resulted in enhanced proliferation and metastasis in vitro and in vivo. The gene discussed is TMSB4X; the disease is head and neck squamous cell carcinoma.